Nikon Announces Artificial Intelligence (AI) for Predictive Imaging, Image Segmentation and Processing

MELVILLE, N.Y., Dec. 16, 2019 /PRNewswire/ — Nikon Instruments Inc., innovator of advanced microscope systems, today announced NIS.ai, a powerful image analysis and processing module for NIS-Elements that leverages Deep Learning and Artificial Intelligence.  NIS.ai is a suite of new AI-based processing tools that utilizes convolutional neural networks to learn from small training datasets supplied by the user.  The training results can then be easily applied to process and analyze huge volumes of data, enabling researchers to increase throughput and expand their application limits. 

NIS.ai includes a suite of applications for predictive imaging, image segmentation and processing:

  • Convert.ai:   Convert.ai learns related patterns present in two different imaging channels.  After training, Convert.ai can then predict the pattern in the second channel even when presented with only the first channel.  DAPI-based staining of nuclei is a common method for cell segmentation and counting.  Convert.ai can be trained to predict where the DAPI label would be based on unstained DIC or phase-contrast images.  This enables users to perform nuclei-based image analysis without ever having to stain samples with DAPI or acquire a fluorescent channel.
  • Segment.aiSegment.ai enables complex structures to be easily identified and segmented.  Neurites in phase-contrast images are traditionally difficult to define by classic thresholding.  Segment.ai can be trained on a small subset of hand-traced neurites to automatically detect and segment neurites from thousands of untraced datasets.
  • Enhance.ai:  Imaging dim fluorescent samples or applications that require low-level light exposure typically result in compromised image quality with poor signal-to-noise ratio.  Enhance.ai learns what a high signal-to-noise image looks like by comparing under-exposed and optimally-exposed images.  Enhance.ai can then restore details in under-exposed or dim fluorescent images, enabling researchers to gain more insights from their low-signal imaging applications.
  • Denoise.ai:  Launched earlier this year, Denoise.ai removes shot noise from resonant confocal images and can be performed in real-time.  Applying Denoise.ai to resonant confocal imaging enables users to acquire confocal images at ultra-high speed without sacrificing image quality.

“The application of Deep Learning and AI to biomedical imaging is extremely powerful, and opening up unseen possibilities,” said Steve Ross, Ph.D., Director, Products & Marketing, Nikon Instruments Inc.  “With NIS.ai, researchers can easily apply deep learning to extract meaningful, unbiased data from large, complex datasets.”

To learn more about NIS.ai, visit: https://www.microscope.healthcare.nikon.com/nis-ai 

About Nikon Instruments Inc.
Nikon Instruments Inc. is the US microscopy arm of Nikon Healthcare, a world leader in the development and manufacture of optical and digital imaging technology for biomedical applications.  Cutting-edge instruments include microscopes, digital imaging products and software.  For more information, visit www.microscope.healthcare.nikon.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/nikon-announces-artificial-intelligence-ai-for-predictive-imaging-image-segmentation-and-processing-300975257.html

SOURCE Nikon Instruments Inc.

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago